Weekly Ophthalmic Newsletter

1. Bausch + Lomb's TENEO? Excimer Laser Yields Positive Results in Clinical Trials

博士伦 's TENEO Excimer Laser has demonstrated promising outcomes in recent studies, reinforcing its potential as a leading tool in refractive surgery.

TENEO is the first excimer laser approved in the U.S. in nearly two decades, distinguished by its 1,740Hz eye-tracker, which operates more than three times faster than the laser's 500Hz repetition rate. This advanced tracking system helps ensure precise laser ablation, even with patient eye movements. These findings highlight the TENEO Excimer Laser's role in advancing patient care by providing surgeons with a reliable and effective solution for improving visual outcomes.

??Learn more about the study, features and expert insights here.

2. European Commission Approves Roche’s Vabysmo for Retinal Vein Occlusion

The European Commission has approved 罗氏公司 Vabysmo? (faricimab) for the treatment of macular edema secondary to retinal vein occlusion (RVO), including both branch and central retinal vein occlusion (BRVO and CRVO).

This approval is a significant milestone, making Vabysmo the first bispecific antibody available in the European Union for this indication, adding to its existing approvals for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).

??Read more about this important approval, key study findings and what it means for RVO patients.

3. Johnson & Johnson's Sight For Kids Program Reaches 50 Million Children

强生公司 , in partnership with the Lions Clubs International Foundation (LCIF), has successfully provided comprehensive eye health services to over 50 million children in underserved communities worldwide through the Sight For Kids program.

The initiative, which began in 2002, has expanded to new regions, including Atlanta, Georgia, and Hong Kong, and was highlighted at the 106th Lions Clubs International Convention in Melbourne, Australia. Launched in partnership with the Lions Clubs International Foundation, this program provides essential vision care services to underprivileged children, helping to detect and address vision problems early.

By reaching this remarkable number, the program has significantly contributed to improving the lives of millions of children, ensuring better educational outcomes and quality of life through early vision intervention.

? Approximately 450 million children and adolescents worldwide have some form of vision condition that requires treatment, with 90 million of these experiencing some degree of sight loss.

??Discover more about the success of the Sight For Kids program here.

Bonus: Top 5 Myths About LASIK Surgery Debunked

LASIK surgery is one of the most popular procedures for correcting vision, but it’s also surrounded by misconceptions.

Our latest article tackles the top 5 myths about LASIK surgery, providing clear, evidence-based information to set the record straight. Whether you’re considering LASIK or just curious about the facts, this article is a must-read for understanding the realities of this life-changing procedure.

??Let's debunk these common LASIK myths.

Enjoy our LinkedIn updates? You can also stay updated with the latest news via email.

? Click here to subscribe and never miss a story!